Barely Significant
← all excerpts

Safety of immune checkpoint inhibitors in cancer patients with COVID-19: A review.

Medicine (Baltimore) · 2025 · PMC12338152 · PMID 40797430

Europe PMCDOI
1
hedged sentence
0.2300
closest p · 4.6× alpha
0.2300
boldest claim

The sentences

did not reach statistical significanceP = .23not close (p > 0.1)
An elevated mortality rate in patients receiving ICI therapy relative to those not receiving such therapy (40.9% vs 28.6%) was noted by Klebanov et al [ 60 ] ; however, this difference did not reach statistical significance ( P = .23).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.